ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

WGSWW GeneDx Holdings Corporation

0.1896
-0.0094 (-4.72%)
Nov 15 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 28,232
Bid Price 0.159
Ask Price 0.6599
News -
Company Name Stock Ticker Symbol Market Type
GeneDx Holdings Corporation WGSWW NASDAQ Equity Warrant
  Price Change Change Percent Stock Price Last Traded
-0.0094 -4.72% 0.1896 16:00:32
Open Price Low Price High Price Close Price Prev Close
0.1756 0.1595 0.1996 0.1896 0.199
Trades Volume VWAP Dollar Volume Avg Volume
72 28,232  0.1702737  4,807 -
Last Trade Time Type Quantity Stock Price Currency
16:00:00 400  0.1896 USD

GeneDx Holdings Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.15M 25.88M - 202.57M -175.77M -6.79 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News GeneDx

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No WGSWW Message Board. Create One! See More Posts on WGSWW Message Board See More Message Board Posts

WGSWW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Companyâ¿¿s segments are GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and womenâ¿¿s health and somatic oncology diagnostic testing and screening products.

Your Recent History

Delayed Upgrade Clock